Entries Tagged "Research"

Aspirin can lower risk of colon cancer for those with Lynch syndrome

A recent study at England’s Universities of Newcastle and Leeds produced encouraging results for people at high-risk of colon cancer. The research studied 861 patients who had Lynch syndrome, or hereditary nonpolyposis colorectal cancer (HNPCC), which is a rare, inherited condition that increases a person's risk of developing colon cancer.

According to the research, taking aspirin daily for several years could help those with Lynch syndrome reduce their chance of developing colon cancer by 63 percent...

Read more.

By Josh Kermisch, executive director of WVCI


Posted December 9, 2011

New cancer cell research may help doctors personalize treatment

New research shows that certain cancer cells, those closest to dying, are more vulnerable and respond better to chemotherapy than those that have not reached the end of life. This new information suggests that the reasons behind the successful use of chemotherapy are more complex than commonly believed.

By better understanding the health and behavior of cancer cells, researchers say it may be possible to test whether a patient will respond well to chemotherapy prior to treatment, according to researchers at Dana-Farber Cancer Institute...

Read more.

By Josh Kermisch, executive director of WVCI


Posted December 23, 2011

Eat more fruits, vegetables and whole grains to reduce cancer risk

Researchers are continuously investigating how diet affects cancer development and what foods may reduce cancer risk. Stanford Medicine compiled study findings about nutrition’s role in reducing risk of common cancers and other diseases. These findings suggest that phytochemicals, anti-oxidants and omega-3 fatty acids, which are compounds found in fruits, vegetables and whole grains, help prevent disease...

Read more.

By WVCI Dietitian Shelly Kokkeler, MS, RD, CSO, LD
 


Posted March 2, 2012

Verdict still out on BPA effects, as controversial decision on ban nears

The U.S. Food and Drug Administration is preparing a decision on whether to ban bisphenol A (BPA), a chemical widely used in plastics and the linings of metal food containers.

The effects of BPA on humans is still being researched, but advocates for a ban on the chemical say it’s better to err on the side of caution by eliminating BPA from the food stream. The FDA is expected to reach a decision by March 31...

Read more.

By Josh Kermisch, executive director of WVCI


Posted March 23, 2012

Research shows targeted therapies for CLL more effective than chemo

It's an exciting time in cancer research, especially concerning chronic lymphocytic lymphoma (CLL). Dr. Jeff Sharman, Willamette Valley Cancer Institute and Research Center's research director, specializes in CLL and presented studies at the American Society of Hematology conference in December. 

While in Atlanta for the conference, he sat down for an interview with Dr. Andrew Schorr of Patient Power to talk about CLL research and how the direction of treatment is changing, from traditional chemotherapy to targeted therapies...

Read more.

By WVCI


Posted January 24, 2013

Dr. Sharman highlighted in U.S. Oncology Network video

Dr. Sharman is highlighted in this U.S. Oncology Network video focusing on his blood cancer research and his studies in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL). 

Read more.

By WVCI


Posted April 23, 2013

Once-in-a-lifetime opportunity to fight cancer

Be a part of the American Cancer Society's groundbreaking study to help us understand and prevent cancer.

Read more.

By WVCI


Posted August 7, 2013

Breakthrough drug tested at WVCI receives FDA approval

Clinical trials overseen by hematologist oncologist Dr. Jeff Sharman at Willamette Valley Cancer Institute and Research Center (WVCI) contributed to FDA approval of a breakthrough drug for chronic lymphocytic leukemia (CLL), a blood and bone marrow disease.

Read more.

By WVCI


Posted November 6, 2013